Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Sosei Heptares wins two Informa Pharma Intelligence Awards Japan

By Brian Buntz | September 2, 2022

Sosei HeptaresTokyo-headquartered biopharma Sosei Heptares (TSE:4565) announced that it had won Licensing Deal of the Year and Executive of the Year at the inaugural Informa Pharma Intelligence Awards Japan.

A panel of experts from academia and business across Japan judged the awards series.

The judges selected Sosei Heptares’ potentially multibillion-dollar alliance with San Diego, California–based Neurocrine Biosciences for the licensing deal award. The two companies are working together to develop novel muscarinic receptor agonists for schizophrenia, dementia and other neurological conditions. Sosei Heptares announced the collaboration in November 2021.

Sosei Heptares could receive up to $2.6 billion in R&D funding and milestone payments while keeping rights to develop M1 muscarinic agonists in Japan for all indications.

The most advanced program involved in the partnership is HTL-0016878, a selective M4 agonist.

Neurocrine Biosciences intends to file an Investigational New Drug (IND) application with the FDA and launch a placebo-controlled Phase 2 trial investigating the drug candidate’s potential as a treatment for schizophrenia before the end of 2022.

The company announced that the Informa Pharma Intelligence Award for executive of the year went to the company’s President and CEO, Chris Cargill. Cargill played a leading role in driving development and milestone periods in the award period of 2021. In addition, Cargill was the company’s chief financial officer at the time of nominations.

Sosei Heptares has partnerships with several prominent pharma companies, including AbbVie, AstraZeneca, Genentech, GSK, Kallyope, Neurocrine Biosciences, Novartis, Pfizer, Takeda and Verily.

In August, Sosei Heptares announced a new pact with AbbVie to explore the potential of small molecules modulating G protein-coupled receptor (GPCR) targets for potential neurological conditions. The partnership will bring together Sosei’s StaR technology and structure-based drug design (SBDD) platform and AbbVie’s proficiency in neuroscience.

In addition to its headquarters in Japan, the company has R&D facilities in Cambridge, UK.

 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE